A K_Ca3.1 Channel Opener, ASP0819, Modulates Nociceptive Signal Processing from Peripheral Nerves in Fibromyalgia-Like Pain in Rats

References

• Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry. 2008;69(Suppl 2):6–13.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28. doi:10.1002/art.1780380104
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–S15. doi:10.1016/j.pain.2010.09.030
   PubMed Web of Science ®Google Scholar
• Staud R. Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol. 2011;29(6 Suppl 69):S109–S117.
   PubMed Web of Science ®Google Scholar
• Serra J, Collado A, Solà R, et al. Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol. 2014;75(2):196–208. doi:10.1002/ana.24065
   PubMed Web of Science ®Google Scholar
• Staud R, Smitherman ML. Peripheral and central sensitization in fibromyalgia: pathogenic role. Current Pain Headache Report. 2002;6(4):259–266. doi:10.1007/s11916-002-0046-1
   PubMedGoogle Scholar
• Häuser W, Walitt B, Fitzcharles MA, Sommer C. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther. 2014;16(1):201. doi:10.1186/ar4441
   PubMed Web of Science ®Google Scholar
• Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem. 2007;14(13):1437–1457. doi:10.2174/092986707780831186
   PubMed Web of Science ®Google Scholar
• Mongan LC, Hill MJ, Chen MX, et al. The distribution of small and intermediate conductance calcium-activated potassium channels in the rat sensory nervous system. Neuroscience. 2005;131(1):161–175. doi:10.1016/j.neuroscience.2004.09.062
   Web of Science ®Google Scholar
• Nagakura Y, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain. 2009;146(1–2):26–33. doi:10.1016/j.pain.2009.05.024
   PubMed Web of Science ®Google Scholar
• Furuta S, Shimizu T, Narita M, et al. Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats. Neuroscience. 2009;164(3):1252–1262. doi:10.1016/j.neuroscience.2009.09.021
   Web of Science ®Google Scholar
• Christophersen P, Wulff H. Pharmacological gating modulation of small- and intermediate-conductance Ca2+-activated K+ channels (KCa2.x and KCa 3.1). Channels. 2015;9(6):336–343. doi:10.1080/19336950.2015.1071748
   PubMed Web of Science ®Google Scholar
• Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997;40(9):1670–1679. doi:10.1002/art.1780400917
   PubMed Web of Science ®Google Scholar
• Bove SE, Calcaterra S, Brooker RM, et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003;11(11):821–830. doi:10.1016/S1063-4584(03)00163-8
   Web of Science ®Google Scholar
• Schäfers M, Sorkinb LS, Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain. 2003;104(3):579–588. doi:10.1016/S0304-3959(03)00115-5
   PubMed Web of Science ®Google Scholar
• Oe T, Tsukamoto M, Nagakura Y. Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats. Neuroscience. 2010;169(4):1860–1871. doi:10.1016/j.neuroscience.2010.06.061
   Web of Science ®Google Scholar
• Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum. 1992;35(5):550–556. doi:10.1002/art.1780350509
   PubMed Web of Science ®Google Scholar
• Wood PB. Role of central dopamine in pain and analgesia. Expert Review Neurotherapy. 2008;8(5):781–797. doi:10.1586/14737175.8.5.781
   PubMedGoogle Scholar
• Murai N, Fushiki H, Honda S, et al. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats. Neuroscience. 2015;289:262–269. doi:10.1016/j.neuroscience.2014.12.065
   Web of Science ®Google Scholar
• Khasar SG, Miao FJP, Jänig W, Levine JD. Modulation of bradykinin-induced mechanical hyperalgesia in the rat by activity in abdominal vagal afferents. European J Neurosci. 1998;10(2):435–444. doi:10.1046/j.1460-9568.1998.00030.x
   Web of Science ®Google Scholar
• Furuta S, Watanabe L, Doi S, et al. Subdiaphragmatic vagotomy increases the sensitivity of lumbar Aδ primary afferent neurons along with voltage-dependent potassium channels in rats. Synapse. 2012;66(2):95–105.
   Web of Science ®Google Scholar
• McHugh D, Head V, Panesar MS, Tigani B, Fox A, Lilley E. Effect of small and intermediate conductance potassium channel modulators on visceral hypersensitivity and function. Gastroenterology. 2008;134(Suppl 1):A–544. doi:10.1016/S0016-5085(08)62540-8
   Google Scholar
• LoVerme J, Russo R, La Rana G, et al. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α. J Pharmacol Exp Ther. 2006;319(3):1051–1061. doi:10.1124/jpet.106.111385
   PubMed Web of Science ®Google Scholar
• Tsantoulas C, McMahon SB. Opening paths to novel analgesics: the role of potassium channels in chronic pain. Trends Neurosci. 2014;37(3):146–158. doi:10.1016/j.tins.2013.12.002
   PubMed Web of Science ®Google Scholar
• Lu R, Flauaus C, Kennel L, et al. KCa3.1 channels modulate the processing of noxious chemical stimuli in mice. Neuropharmacology. 2017;125:386–395. doi:10.1016/j.neuropharm.2017.08.021
   Web of Science ®Google Scholar
• Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. PEA was significantly higher than those of ibuprofen in temporomandibular joint. J Orofac Pain. 2012;26(2):99–104.
   PubMedGoogle Scholar
• Meseguer V, Karashima Y, Talavera K, et al. Transient receptor potential channels in sensory neurons are targets of the antimycotic agent clotrimazole. J Neurosci. 2008;28(3):576–586. doi:10.1523/JNEUROSCI.4772-07.2008
   Web of Science ®Google Scholar
• Binet O, Soto-Melo J, Delgadillo J, Videla S, Izquierdo I. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole study group. Mycoses. 1994;37(11–12):455–459. doi:10.1111/j.1439-0507.1994.tb00400.x
   Web of Science ®Google Scholar
• Yoshimi E, Kumakura F, Hatori C, et al. Antinociceptive effects of AS1892802, a novel Rho kinase inhibitor, in rat models of inflammatory and noninflammatory arthritis. J Pharmacol Exp Ther. 2010;334(3):955–963. doi:10.1124/jpet.110.167924
   Web of Science ®Google Scholar
• Nagase H, Kumakura S, Shimada K. Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee. J Pharmacol Toxicol Methods. 2012;65(1):29–36. doi:10.1016/j.vascn.2011.10.002
   Web of Science ®Google Scholar
• Baxter DF, Kirk M, Garcia AF, et al. A novel membrane-sensitive fluorescent dye improves cell-based assays for ion channels. J Biomol Screen. 2002;7(1):79–85. doi:10.1177/108705710200700110
   Google Scholar